-transparent.png){kind=logo}
Amongst the surgical treatments that have been suggested for refractory ascites, the one that has met with the greatest success is the LeVeen shunt. It nevertheless involves certain risks and might even be fatal. The authors' brief experience in this domain has confirmed its positive immediate effects and has also brought to light some of its drawbacks. The large number of potential complications leads one to conclude that the LeVeen shunt should be reserved for refractory ascites and hepato-renal syndrome, and should not be prematurely employed in other situations.
Related Publications
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
January 1983,
Der Internist,
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
May 1981,
Revista espanola de anestesiologia y reanimacion,
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
January 1986,
Journal of hepatology,
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
November 1978,
Deutsche medizinische Wochenschrift (1946),
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
September 1978,
The Central African journal of medicine,
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
August 1988,
Minerva chirurgica,
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
August 1978,
Journal of the Iowa Medical Society,
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
January 1998,
Annales de chirurgie,
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
July 1983,
Annals of surgery,
J J Gonvers, and
P Loup, and
H R Brunner, and
R Mosimann, and
J R Hofstetter
April 1980,
Annals of internal medicine,
